Literature DB >> 32071459

[Anti-inflammatory and repaired effects of non-steroidal anti-inflammatory drugs on human dental pulp cells].

J Y Li1, S N Wang1, Y M Dong1.   

Abstract

OBJECTIVE: To study the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on anti-inflammation and repair of human dental pulp cells (hDPCs).
METHODS: Primary hDPCs from the freshly extracted human third molars were cultured and passaged in vitro, and the following experiments were performed using the 4th-6th generations of hDPCs. HDPCs were cultured in Dulbecco's modified eagle medium (DMEM) containing 1 mg/L lipopolysaccharide (LPS) to obtain LPS irritated hDPCs (LPS-hDPCs), which served as the inflammatory positive group. LPS-hDPCs in the experimental group were cultured in DMEM containing different concentrations (1, 10, and 100 μmol/L) of NSAIDs (aspirin or meloxicam). HDPCs cultured in DMEM were used as the negative control group. The effects of NSAIDs on the proliferation of hDPCs were assessed on the 1st, 3rd, 5th, and 7th day by MTT assay. The effects of NSAIDs on the expression of inflammation related genes interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) of LPS-hDPCs were detected at the 6th hour by real-time PCR. The expression of differentiation related markers dentin matrix protein-1 (DMP-1) and dentin sialophosphoprotein (DSPP) were detected on the 7th day by real-time PCR. The effects of NSAIDs on the mineralization of LPS-hDPCs were assesd on the 14th day by alizarin red staining. Calcium mineralized nodules were semi-quantitatively determined by cetyl pyridine chloride.
RESULTS: MTT assay showed that 1-100 μmol/L aspirin or meloxicam significantly promoted the proliferation of hDPC in a concentration dependent manner (P<0.05). Real-time PCR showed that 1-100 μmol/L meloxicam or 100 μmol/L aspirin down-regulated significantly the mRNA expression of TNF-α and IL-6 of LPS-hDPCs (P<0.05), and 100 μmol/L meloxicam down-regulated IL-6 and TNF-α more significantly than 100 μmol/L aspirin of LPS-hDPCs (P<0.05). Real-time PCR showed that 100 μmol/L meloxicam up-regulated the mRNA expression of DMP-1 and DSPP of LPS-hDPCs significantly (P<0.05). Alizarin red staining showed the meloxicam at the concentration of 100 μmol/L significantly promoted the mineralization of LPS-hDPCs (P<0.05).
CONCLUSION: In this study, meloxicam promoted the proliferation of hDPCs, inhibited the inflammatory reaction and promoted differentiation and mineralization of hDPCs under LPS irritation. The present results suggest that meloxicam may play a role in anti-inflammation and repair of pulp inflammation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32071459      PMCID: PMC7439056     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  21 in total

1.  Meloxicam medication reduces orthodontically induced dental root resorption and tooth movement velocity: a combined in vivo and in vitro study of dental-periodontal cells and tissue.

Authors:  Christian Kirschneck; Matthias Meier; Kathrin Bauer; Peter Proff; Jochen Fanghänel
Journal:  Cell Tissue Res       Date:  2017-01-03       Impact factor: 5.249

2.  Detection of interleukin-6 in human dental pulp and periapical lesions.

Authors:  R A Barkhordar; C Hayashi; M Z Hussain
Journal:  Endod Dent Traumatol       Date:  1999-02

3.  Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.

Authors:  Bruno César de Vasconcelos Gurgel; Krysna Torres de Almeida; Raniel Fernandes Peixoto; Kenio Costa Lima; Kamila Rosamilia Kantovitz; Francisco Humberto; Sergio de Toledo
Journal:  Braz Dent J       Date:  2017 Mar-Apr

4.  Detection of tumor necrosis factor alpha in normal and inflamed human dental pulps.

Authors:  Sonja Pezelj-Ribaric; Ivica Anic; Ivana Brekalo; Ivana Miletic; Milena Hasan; Marica Simunovic-Soskic
Journal:  Arch Med Res       Date:  2002 Sep-Oct       Impact factor: 2.235

5.  Effects of NSAIDs on the osteogenic differentiation of human adipose tissue-derived stromal cells.

Authors:  Chrystalleni Hadjicharalambous; Vasileia Ismini Alexaki; Kalliopi Alpantaki; Maria Chatzinikolaidou
Journal:  J Pharm Pharmacol       Date:  2016-08-14       Impact factor: 3.765

6.  LPS promote the odontoblastic differentiation of human dental pulp stem cells via MAPK signaling pathway.

Authors:  Wenxi He; Zhihua Wang; Zhirong Luo; Qing Yu; Yong Jiang; Yaqing Zhang; Zeyuan Zhou; Anthony J Smith; Paul R Cooper
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

7.  Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling.

Authors:  Guijuan Feng; Ke Zheng; Tong Cao; Jinlong Zhang; Min Lian; Dan Huang; Changbo Wei; Zhifeng Gu; Xingmei Feng
Journal:  Cytotechnology       Date:  2018-02-26       Impact factor: 2.058

8.  Cytokine signalling in rat pulp interstitial fluid and transcapillary fluid exchange during lipopolysaccharide-induced acute inflammation.

Authors:  Athanasia Bletsa; Ellen Berggreen; Inge Fristad; Olav Tenstad; Helge Wiig
Journal:  J Physiol       Date:  2006-03-09       Impact factor: 5.182

9.  Effects of lipopolysaccharides on human dental pulp cells.

Authors:  A Nakane; T Yoshida; K Nakata; N Horiba; H Nakamura
Journal:  J Endod       Date:  1995-03       Impact factor: 4.171

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  2 in total

1.  Anti-Inflammatory and Mineralization Effects of an ASP/PLGA-ASP/ACP/PLLA-PLGA Composite Membrane as a Dental Pulp Capping Agent.

Authors:  Wenjuan Yan; Fenghe Yang; Zhongning Liu; Quan Wen; Yike Gao; Xufeng Niu; Yuming Zhao
Journal:  J Funct Biomater       Date:  2022-07-29

2.  The effect of topical application of meloxicam on inflamed dental pulp.

Authors:  Jing-Yi Li; Sai-Nan Wang; Yan-Mei Dong
Journal:  J Dent Sci       Date:  2020-12-02       Impact factor: 2.080

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.